A new immunogenicity epitope for immune therapies

Title:

A new immunogenicity epitope for immune therapies

Document Type and Number:

Japanese Patent JP6130469

Kind Code:

B2

Abstract:

The present invention relates to amino acid sequences of peptides derived from tumour associated antigens that are able to bind to MHC complexes of either class, and elicit an immune response, as well as to uses of said peptides for the treatment of diseases.

More Like This:

JP3375130	[Title of Invention] Biological protein
JP2007125032	SPECIFIC AND UNIVERSAL PROBES AND AMPLIFICATION PRIMERS TO RAPIDLY DETECT AND IDENTIFY COMMON BACTERIAL PATHOGENS AND ANTIBIOTIC RESISTANT GENES FROM CLINICAL SPECIMENS FOR ROUTINE DIAGNOSIS IN MICROBIOLOGY LABORATORIES
WO/1999/057144	HUMAN TRANSCRIPTIONAL REGULATOR MOLECULES

Inventors:

Shin, Harpreet
Shall, Oliver
Troutvine, Claudia
Hirff, Norbert
Weinschenk, Toni
Walter, Steffen
Peter Rewandrowski

Application Number:

JP2015225284A

Publication Date:

May 17, 2017

Filing Date:

November 18, 2015

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Imatics Biotechnology GM Behr

International Classes:

C12N15/09; A61K31/7088; A61K38/00; A61K39/00; A61P35/00; C07K7/06; C07K14/435; C07K19/00; C12N5/0783; C12N5/22

Domestic Patent References:

JP10262685A
JP2002173450A

Foreign References:

WO2007028574A1
WO2007018047A1
WO2007014740A1
WO2006124700A1

Attorney, Agent or Firm:

Takashi Shoji

Previous Patent: Charger

Next Patent: CAMERA WITH FLASH DEVICE